HEMOPHILIA ASSOCIATION OF NEW YORK INC

Balance Sheet
Fiscal Year: 2025
Assets in 2025 (Year End)
$4,358,738
Investments
47%
Receivables (Non-Related)
30%
Property, Plant, & Equipment (net)
19%
Cash & Equivalents
3%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2025 (Year End)
$224,150
Payables & Accruals
74%
Deferred Revenue
26%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2024
2025
Change
Cash & Equivalents
$44,697
$150,794
+237%
Receivables (Non-Related)
$1,693,948
$1,292,521
-24%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$89,215
$42,853
-52%
Investments
$1,933,017
$2,064,094
+7%
Property, Plant, & Equipment (net)
$835,342
$808,476
-3%
Other Assets
-
-
-
Total Assets
$4,596,219
$4,358,738
-5%
Liabilities
2024
2025
Change
Payables & Accruals
$104,123
$166,150
+60%
Grants Payable
-
-
-
Deferred Revenue
$3,250
$58,000
+1685%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$107,373
$224,150
+109%
Net assets
2024
2025
Change
Restricted Net Assets
$1,764,935
$1,242,978
-30%
Unrestricted Net Assets
$2,723,911
$2,891,610
+6%
Net assets
2024
2025
Change
Net assets
+$4,488,846
+$4,134,588
-8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)